The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma

OBJECTIVE: To determine the safety of hepatectomy after combined lenvatinib and anti-PD-1 preoperative systemic therapy (PST) in patients with marginally resectable hepatocellular carcinoma (HCC). BACKGROUND: PST followed by hepatectomy (PSTH) is an emerging treatment for HCC. However, the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ying-Hao, Huang, Cheng, Zhu, Xiao-Dong, Xu, Ming-Hao, Chen, Zhao-Shuo, Tan, Chang-Jun, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2022
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431521/
https://www.ncbi.nlm.nih.gov/pubmed/37601608
http://dx.doi.org/10.1097/AS9.0000000000000163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431521/
https://www.ncbi.nlm.nih.gov/pubmed/37601608
http://dx.doi.org/10.1097/AS9.0000000000000163

Ejemplares similares